Dixon Hubard Feinour & Brown’s Labcorp LH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
$393K Hold
1,950
0.05% 214
2022
Q1
$442K Hold
1,950
0.04% 229
2021
Q4
$526K Buy
+1,950
New +$483K 0.05% 206
2017
Q4
Sell
-42,874
Closed -$5.56M 198
2017
Q3
$5.56M Sell
42,874
-1,181
-3% -$158K 1.6% 19
2017
Q2
$5.83M Sell
44,055
-303
-0.7% -$37.1K 1.69% 18
2017
Q1
$5.47M Buy
44,358
+35
+0.1% +$4.14K 1.63% 20
2016
Q4
$4.89M Sell
44,323
-2,508
-5% -$279K 1.55% 24
2016
Q3
$5.53M Buy
+46,831
New +$5.52M 1.72% 21

Other funds holding LH

Dixon Hubard Feinour & Brown's LH Position: Q2 2022 in Review

Dixon Hubard Feinour & Brown held its Labcorp (LH) position steady in Q2 2022 at 1,950 shares worth $393K. The position accounts for 0.05% of the portfolio, ranked #214.

Dixon Hubard Feinour & Brown first reported a position in LH in Q3 2016 and has held it in 8 quarters since. The position peaked at $5.83M in Q2 2017. 966 funds tracked by Wall St. Rank hold LH as of Q2 2022.

  • Dixon Hubard Feinour & Brown held 1,950 shares of Labcorp worth $393K as of Q2 2022.
  • Dixon Hubard Feinour & Brown left its Labcorp share count unchanged in Q2 2022.
  • Labcorp made up 0.05% of Dixon Hubard Feinour & Brown's portfolio in Q2 2022, its #214 holding.
  • Dixon Hubard Feinour & Brown first reported a position in Labcorp in Q3 2016 and has held it in 8 quarters since.
  • Dixon Hubard Feinour & Brown's Labcorp position peaked at $5.83M in Q2 2017.
  • 966 funds tracked by Wall St. Rank held Labcorp as of Q2 2022.

Based on Dixon Hubard Feinour & Brown's 13F filing for Q2 2022, filed 22 Jul 2022.